Inotropes and vasopressors in adults and foals

Veterinary Clinics of North America - Equine Practice

Volumn 20, Issue 1, 2004, Pages 77-106

  Corley, Kevin T T ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ADRENOMEDULLIN; ALPHA ADRENERGIC RECEPTOR; CATECHOLAMINE; CORTICOSTEROID; DOBUTAMINE; DOPAMINE; FLUDROCORTISONE; HEMOGLOBIN; HYDROCORTISONE; HYPERTENSIVE AGENT; INOTROPIC AGENT; ISOPRENALINE; METHYLENE BLUE; NITRIC OXIDE; NORADRENALIN; PHENYLEPHRINE; TERLIPRESSIN; VASOPRESSIN;

ADRENAL INSUFFICIENCY; ARTERIAL PRESSURE; BLOOD FLOW; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; ENDOTOXEMIA; FLUID THERAPY; HEART OUTPUT; HUMAN; HYPOTENSION; KIDNEY DISEASE; NONHUMAN; POTASSIUM CHANNEL; REGIONAL PERFUSION; REVIEW; SHOCK; SIDE EFFECT; VASCULAR RESISTANCE; VASODILATATION;

ANIMALS; ANIMALS, NEWBORN; BLOOD PRESSURE; CARDIOTONIC AGENTS; HEMODYNAMIC PROCESSES; HORSE DISEASES; HORSES; REGIONAL BLOOD FLOW; TREATMENT OUTCOME; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS;

EID: 4143146597     PISSN: 07490739     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cveq.2003.12.003     Document Type: Review

References (155)

1. Corley K.T.T., Donaldson L.L., Durando M.M., et al. Cardiac output technologies with special reference to the horse. J Vet Intern Med. 17:(3):2003;262-272
2. Corley K.T.T., McKenzie H.C., Amoroso L.M., et al. Initial experience with norepinephrine infusion in hypotensive critically ill foals. J Vet Emerg Crit Care. 10:(4):2000;267-276
3. Corley KTT. Managing fluid refractory hypotension in critically ill neonatal foals - inotropes and pressors. In: Proceedings of the American College of Veterinary Internal Medicine. Denver; 2001. p. 239-41.
4. Corley K.T.T. Monitoring and treating haemodynamic disturbances in critically ill neonatal foals Part I - haemodynamic monitoring. Equine Vet Educ. 14:(5):2002;270-279
5. Corley K.T.T. Monitoring and treating haemodynamic disturbances in critically ill neonatal foals Part II - assessment and treatment. Equine Vet Educ. 14:(6):2002;328-336
6. Bottoms G.D., Fessler J.F., Roesel O.F., et al. Endotoxin-induced hemodynamic changes in ponies: effects of flunixin meglumine. Am J Vet Res. 42:(9):1981;1514-1518
7. Templeton C.B., Bottoms G.D., Fessler J.F., et al. Effects of repeated endotoxin injections on prostanoids, hemodynamics, endothelial cells, and survival in ponies. Circ Shock. 16:(3):1985;253-264
8. Wang P., Yoo P., Zhou M., et al. Reduction in vascular responsiveness to adrenomedullin during sepsis. J Surg Res. 85:(1):1999;59-65
9. Wang P. Adrenomedullin and cardiovascular responses in sepsis. Peptides. 22:(11):2001;1835-1840
10. Hyvelin J.M., Shan Q., Bourreau J.P. Adrenomedullin: a cardiac depressant factor in septic shock. J Card Surg. 17:(4):2002;328-335
11. Levy B., Bollaert P.E., Charpentier C., et al. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study. Intensive Care Med. 23:(3):1997;282-287
12. Meier-Hellmann A., Sakka S.G., Reinhart K. Catecholamines and splanchnic perfusion. Schweiz Med Wochenschr. 130:(50):2000;1942-1947
13. Lavoie J.P., Madigan J.E., Cullor J.S., et al. Haemodynamic, pathological, haematological and behavioural changes during endotoxin infusion in equine neonates. Equine Vet J. 22:(1):1990;23-29
14. Clark E.S., Gantley B., Moore J.N. Effects of slow infusion of a low dosage of endotoxin on systemic haemodynamics in conscious horses. Equine Vet J. 23:(1):1991;18-21
15. Rose R.J. A physiological approach to fluid and electrolyte therapy in the horse. Equine Vet J. 13:(1):1981;7-14
16. Mills P.C., Ng J.C., Seawright A.A., et al. Kinetics, dose response, tachyphylaxis and cross-tachyphylaxis of vascular leakage induced by endotoxin, zymosan-activated plasma and platelet-activating factor in the horse. J Vet Pharmacol Ther. 18:(3):1995;204-209
17. Henninger D.D., Snyder J.R., Pascoe J.R., et al. Microvascular permeability changes in ischemia/reperfusion injury in the ascending colon of horses. J Am Vet Med Assoc. 201:(8):1992;1191-1196
18. Dabareiner R.M., Snyder J.R., White N.A., et al. Microvascular permeability and endothelial cell morphology associated with low-flow ischemia/reperfusion injury in the equine jejunum. Am J Vet Res. 56:(5):1995;639-648
19. Ognibene F.P., Parker M.M., Natanson C., et al. Depressed left ventricular performance. Response to volume infusion in patients with sepsis and septic shock. Chest. 93:(5):1988;903-910
20. Parker M.M., Shelhamer J.H., Bacharach S.L., et al. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med. 100:(4):1984;483-490
21. Parker M.M., McCarthy K.E., Ognibene F.P., et al. Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest. 97:(1):1990;126-131
22. McKenzie H.C., Furr M.O. Equine neonatal sepsis: the pathophysiology of severe inflammation and infection. Compend Contin Educ Pract Vet. 23:(7):2001;661-672
23. Moore J.N., Barton M.H. An update on endotoxaemia Part 1: mechanisms and pathways. Equine Vet Educ. 10:(6):1998;300-306
24. Finkel M.S., Oddis C.V., Jacob T.D., et al. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 257:(5068):1992;387- 389
25. Khadour F.H., Panas D., Ferdinandy P., et al. Enhanced NO and superoxide generation in dysfunctional hearts from endotoxemic rats. Am J Physiol. 283:(3):2002;H1108-H1115
26. Brady A.J., Poole Wilson P.A., Harding S.E., et al. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol. 263:(6 Part 2):1992;H1963-H1966
27. Brady A.J., Warren J.B., Poole Wilson P.A., et al. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol. 265:(1 Part 2):1993;H176-H182
28. Fahey T.J., Yoshioka T., Shires G.T., et al. The role of tumor necrosis factor and nitric oxide in the acute cardiovascular response to endotoxin. Ann Surg. 223:(1):1996;63-69
29. Slack J.A., McGuirk S.M., Darien B.J., et al. Biochemical evidence of myocardial injury in septic foals. J Vet Intern Med. 17:(3):2003;387-388
30. Ganong W.F. Cardiovascular homeostasis in health and disease. Review of medical physiology. 19th edition :1999;601-616 Appleton & Lange, Stamford, CT
31. Benedict C.R., Rose J.A. Arterial norepinephrine changes in patients with septic shock. Circ Shock. 38:(3):1992;165-172
32. Sylvester J.T., Scharf S.M., Gilbert R.D., et al. Hypoxic and CO hypoxia in dogs: hemodynamics, carotid reflexes, and catecholamines. Am J Physiol. 236:(1):1979;H22-H28
33. Cumming A.D., Driedger A.A., McDonald J.W., et al. Vasoactive hormones in the renal response to systemic sepsis. Am J Kidney Dis. 11:(1):1988;23-32
34. Landry D.W., Oliver J.A. The pathogenesis of vasodilatory shock. N Engl J Med. 345:(8):2001;588-595
35. Ochoa J.B., Udekwu A.O., Billiar T.R., et al. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg. 214:(5):1991;621-626
36. MacMicking J.D., Nathan C., Hom G., et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 81:(4):1995;641-650
37. Tsuneyoshi I., Kanmura Y., Yoshimura N. Nitric oxide as a mediator of reduced arterial responsiveness in septic patients. Crit Care Med. 24:(6):1996;1083-1086
38. Elliott J., Bryant C.E., Soydan J. The role of nitric oxide in the responses of equine digital veins to vasodilator and vasoconstrictor agents. Equine Vet J. 26:(5):1994;378-384
39. Mirza M.H., Oliver J.L., Seahorn T.L., et al. Detection and comparison of nitric oxide in clinically normal horses and those with naturally acquired small intestinal strangulation obstruction. Can J Vet Res. 63:(4):1999;230-240
40. Polkes A.C., MacKay R.J., Moore R.M., et al. Plasma nitric oxide concentrations in sick neonatal foals as compared to healthy neonatal foals. J Vet Intern Med. 14:(3):2000;333
41. Chernow B., Roth B.L. Pharmacologic manipulation of the peripheral vasculature in shock: clinical and experimental approaches. Circ Shock. 18:(2):1986;141-155
42. Boczkowski J., Lisdero C.L., Lanone S., et al. Endogenous peroxynitrite mediates mitochondrial dysfunction in rat diaphragm during endotoxemia. FASEB J. 13:(12):1999;1637-1646
43. Takakura K., Taniguchi T., Muramatsu I., et al. Modification of alpha1-adrenoceptors by peroxynitrite as a possible mechanism of systemic hypotension in sepsis. Crit Care Med. 30:(4):2002;894-899
44. Zingarelli B., Day B.J., Crapo J.D., et al. The potential role of peroxynitrite in the vascular contractile and cellular energetic failure in endotoxic shock. Br J Pharmacol. 120:(2):1997;259-267
45. Macarthur H., Westfall T.C., Riley D.P., et al. Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock. Proc Natl Acad Sci USA. 97:(17):2000;9753-9758
46. Landry D.W., Levin H.R., Gallant E.M., et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation. 95:(5):1997;1122-1125
47. Sharshar T., Blanchard A., Paillard M., et al. Circulating vasopressin levels in septic shock. Crit Care Med. 31:(6):2003;1752-1758
48. Baker C.H., Sutton E.T., Zhou Z., et al. Microvascular vasopressin effects during endotoxin shock in the rat. Circ Shock. 30:(2):1990;81-95
49. Wilson M.F., Brackett D.J., Hinshaw L.B., et al. Vasopressin releasing during sepsis and septic shock in baboons and dogs. Surg Gynecol Obstet. 153:(6):1981;869-872
50. Rothwell P.M., Udwadia Z.F., Lawler P.G. Cortisol response to corticotropin and survival in septic shock. Lancet. 337:(8741):1991;582-583
51. Annane D., Bellissant E., Sebille V., et al. Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve. Br J Clin Pharmacol. 46:(6):1998;589-597
52. Kitamura K., Kangawa K., Kawamoto M., et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun. 192:(2):1993;553-560
53. He H., Bessho H., Fujisawa Y., et al. Effects of a synthetic rat adrenomedullin on regional hemodynamics in rats. Eur J Pharmacol. 273:(3):1995;209-214
54. Westphal M., Stubbe H., Bone H.G., et al. Hemodynamic effects of exogenous adrenomedullin in healthy and endotoxemic sheep. Biochem Biophys Res Commun. 296:(1):2002;134-138
55. Hirata Y., Mitaka C., Sato K., et al. Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis. J Clin Endocrinol Metab. 81:(4):1996;1449-1453
56. Wang P., Zhou M., Ba Z.F., et al. Up-regulation of a novel potent vasodilatory peptide adrenomedullin during polymicrobial sepsis. Shock. 10:(2):1998;118-122
57. Yang S., Zhou M., Chaudry I.H., et al. Novel approach to prevent the transition from the hyperdynamic phase to the hypodynamic phase of sepsis: role of adrenomedullin and adrenomedullin binding protein-1. Ann Surg. 236:(5):2002;625-633
58. Quayle J.M., Nelson M.T., Standen N.B. ATP-sensitive and inwardly rectifying potassium channels in smooth muscle. Physiol Rev. 77:(4):1997;1165-1232
59. Davies N.W. Modulation of ATP-sensitive K+ channels in skeletal muscle by intracellular protons. Nature. 343:(6256):1990;375-377
60. Keung E.C., Li Q. Lactate activates ATP-sensitive potassium channels in guinea pig ventricular myocytes. J Clin Invest. 88:(5):1991;1772-1777
61. Gardiner S.M., Kemp P.A., March J.E., et al. Regional haemodynamic responses to infusion of lipopolysaccharide in conscious rats: effects of pre- or post-treatment with glibenclamide. Br J Pharmacol. 128:(8):1999;1772-1778
62. Fink M. Cytopathic hypoxia in sepsis. Acta Anaesthesiol Scand Suppl. 110:1997;87-95
63. Preiser J.C., Zhang H., Debelle F., et al. Hemodynamic effects of glibenclamide during endotoxemia: contrasting findings in vitro versus in vivo. Shock. 19:(3):2003;223-228
64. Ganong W.F. Cardiovascular regulatory mechanisms. Review of medical physiology. 19th edition :1999;568-581 Appleton & Lange, Stamford, CT
65. Stepp D.W., Kroll K., Feigl E.O. K+ ATP channels and adenosine are not necessary for coronary autoregulation. Am J Physiol. 273:(3 Part 2):1997;H1299-H1308
66. Okazaki K., Endou M., Okumura F. Involvement of barium-sensitive K+ channels in endothelium-dependent vasodilation produced by hypercapnia in rat mesenteric vascular beds. Br J Pharmacol. 125:(1):1998;168-174
67. Bayerle Eder M., Wolzt M., Polska E., et al. Hypercapnia-induced cerebral and ocular vasodilation is not altered by glibenclamide in humans. Am J Physiol. 278:(6):2000;R1667-R1673
68. Adams H.R. Adrenergic agonists and antagonists. Veterinary pharmacology and therapeutics. 7th edition :1995;Iowa State Press, Ames, Iowa
69. Chapman D.I., Marcroft J. Studies on the metabolism of sympathomimetic amines. The metabolism of (plus or minus)-(14C) adrenaline in the horse. Xenobiotica. 3:(11):1973;745-751
70. Chapman D.I., Marcroft J. Studies on the metabolism of sympathomimetic amines. The metabolism of (plus or minus)-(14C) noradrenaline in the horse. Xenobiotica. 3:(6):1973;389-397
71. Uusaro A., Russell J.A. Could anti-inflammatory actions of catecholamines explain the possible beneficial effects of supranormal oxygen delivery in critically ill surgical patients? Intensive Care Med. 26:(3):2000;299-304
72. van der Poll T., Jansen J., Endert E., et al. Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood. Infect Immun. 62:(5):1994;2046-2050
73. van der Poll T., Coyle S.M., Barbosa K., et al. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J Clin Invest. 97:(3):1996;713-719
74. van der Poll T., Levi M., Dentener M., et al. Epinephrine exerts anticoagulant effects during human endotoxemia. J Exp Med. 185:(6):1997;1143- 1148
75. van der Poll T., Lowry S.F. Epinephrine inhibits endotoxin-induced IL-1 beta production: roles of tumor necrosis factor-alpha and IL-10. Am J Physiol. 273:(6 Part 2):1997;R1885-R1890
76. De Backer D., Zhang H., Manikis P., et al. Regional effects of dobutamine in endotoxic shock. J Surg Res. 65:(2):1996;93-100
77. Secchi A., Wellmann R., Martin E., et al. Dobutamine maintains intestinal villus blood flow during normotensive endotoxemia: an intravital microscopic study in the rat. J Crit Care. 12:(3):1997;137-141
78. Nevière R., Mathieu D., Chagnon J.L., et al. The contrasting effects of dobutamine and dopamine on gastric mucosal perfusion in septic patients. Am J Respir Crit Care Med. 154:(6 Part 1):1996;1684-1688
79. Fink M.P., Kaups K.L., Wang H.L., et al. Maintenance of superior mesenteric arterial perfusion prevents increased intestinal mucosal permeability in endotoxic pigs. Surgery. 110:(2):1991;154-160
80. Duranteau J., Sitbon P., Teboul J.L., et al. Effects of epinephrine, norepinephrine, or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock. Crit Care Med. 27:(5):1999;893-900
81. Levy B., Bollaert P.E., Lucchelli J.P., et al. Dobutamine improves the adequacy of gastric mucosal perfusion in epinephrine-treated septic shock. Crit Care Med. 25:(10):1997;1649-1654
82. Sun Q., Tu Z., Lobo S., et al. Optimal adrenergic support in septic shock due to peritonitis. Anesthesiology. 98:(4):2003;888-896
83. Shoemaker W.C., Appel P.L., Kram H.B. Hemodynamic and oxygen transport effects of dobutamine in critically ill general surgical patients. Crit Care Med. 14:(12):1986;1032-1037
84. Vischer C.M., Foreman J.H., Constable P.D., et al. Hemodynamic effects of thyroidectomy in sedentary horses. Am J Vet Res. 60:(1):1999;14-21
85. Martin C., Perrin G., Saux P., et al. Effects of norepinephrine on right ventricular function in septic shock patients. Intensive Care Med. 20:(6):1994;444-447
86. Martin C., Papazian L., Perrin G., et al. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest. 103:(6):1993;1826-1831
87. Martin C., Viviand X., Leone M., et al. Effect of norepinephrine on the outcome of septic shock. Crit Care Med. 28:(8):2000;2758-2765
88. Bellomo R., Kellum J.A., Wisniewski S.R., et al. Effects of norepinephrine on the renal vasculature in normal and endotoxemic dogs. Am J Respir Crit Care Med. 159:(4 Part 1):1999;1186-1192
89. Di Giantomasso D., May C.N., Bellomo R. Norepinephrine and vital organ blood flow during experimental hyperdynamic sepsis. Intensive Care Med. 29:2003;1774-1781
90. De Backer D., Creteur J., Silva E., et al. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? Crit Care Med. 31:(6):2003;1659-1667
91. Levy B., Mansart A., Bollaert P.E., et al. Effects of epinephrine and norepinephrine on hemodynamics, oxidative metabolism and organ energetics in endotoxemic rats. Intensive Care Med. 29:(2):2003;292-300
92. Levy B. Epinephrine in septic shock: Dr. Jekyll or Mr. Hyde? Crit Care Med. 31:(6):2003;1866-1867
93. Hardy J., Bednarski R.M., Biller D.S. Effect of phenylephrine on hemodynamics and splenic dimensions in horses. Am J Vet Res. 55:(11):1994;1570-1578
94. Flancbaum L., Dick M., Dasta J., et al. A dose-response study of phenylephrine in critically ill, septic surgical patients. Eur J Clin Pharmacol. 51:(6):1997;461-465
95. Corley K.T.T., Donaldson L.L., Furr M.O. Comparison of lithium dilution and thermodilution cardiac output measurements in anaesthetised neonatal foals. Equine Vet J. 34:(6):2002;598-601
96. Gregory J.S., Bonfiglio M.F., Dasta J.F., et al. Experience with phenylephrine as a component of the pharmacologic support of septic shock. Crit Care Med. 19:(11):1991;1395-1400
97. Yamazaki T., Shimada Y., Taenaka N., et al. Circulatory responses to afterloading with phenylephrine in hyperdynamic sepsis. Crit Care Med. 10:(7):1982;432-435
98. Segal J.M., Phang P.T., Walley K.R. Low-dose dopamine hastens onset of gut ischemia in a porcine model of hemorrhagic shock. J Appl Physiol. 73:(3):1992;1159-1164
99. MacGregor D.A., Smith T.E., Prielipp R.C., et al. Pharmacokinetics of dopamine in healthy male subjects. Anesthesiology. 92:(2):2000;338-346
100. Van den Berghe G., de Zegher F. Anterior pituitary function during critical illness and dopamine treatment. Crit Care Med. 24:(9):1996;1580-1590
101. van de Borne P., Oren R., Somers V.K. Dopamine depresses minute ventilation in patients with heart failure. Circulation. 98:(2):1998;126-131
102. Trim C.M., Moore J.N., Clark E.S. Renal effects of dopamine infusion in conscious horses. Equine Vet J Suppl. 71:1989;24-28
103. Denton M.D., Chertow G.M., Brady H.R. "Renal-dose" dopamine for the treatment of acute renal failure: scientific rationale, experimental studies and clinical trials. Kidney Int. 50:(1):1996;4-14
104. Australian and New Zealand Intensive Care Society Clinical Trials Group. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Lancet. 356:2000;2139-2143
105. Kellum J.A., Decker J.M. Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med. 29:(8):2001;1526-1531
106. Landry D.W., Levin H.R., Gallant E.M., et al. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med. 25:(8):1997;1279-1282
107. Bartelstone H.J., Nasmyth P.A. Vasopressin potentiation of catecholamine actions in dog, rat, cat, and rat aortic strip. Am J Physiol. 208:1965;754-762
108. Wakatsuki T., Nakaya Y., Inoue I. Vasopressin modulates K(+)-channel activities of cultured smooth muscle cells from porcine coronary artery. Am J Physiol. 263:(2 Part 2):1992;H491-H496
109. Umino T., Kusano E., Muto S., et al. AVP inhibits LPS- and IL-1beta-stimulated NO and cGMP via V1 receptor in cultured rat mesangial cells. Am J Physiol. 276:(3 Part 2):1999;F433-F441
110. Malay M.B., Ashton R.C., Landry D.W., et al. Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma. 47:(4):1999;699-703
111. Patel B.M., Chittock D.R., Russell J.A., et al. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology. 96:(3):2002;576-582
112. Holmes C.L., Walley K.R., Chittock D.R., et al. The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med. 27:(8):2001;1416-1421
113. O'Brien A., Clapp L., Singer M. Terlipressin for norepinephrine-resistant septic shock. Lancet. 359:(9313):2002;1209-1210
114. Westphal M., Bone H.-G., Van Aken H., et al. Terlipressin for haemodynamic support in septic patients: a double-edged sword? Lancet. 360:(9341):2002;1250-1251
115. Asfar P., Pierrot M., Veal N., et al. Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endotoxic rats. Crit Care Med. 31:(1):2003;215-220
116. Palmer J.E. Foal cardiopulmonary resuscitation. Orsini J.A., Divers T.J. Manual of equine emergencies. 2nd edition :2003;581-614 WB Saunders, Philadelphia
117. Westphal M., Stubbe H., Sielenkamper A.W., et al. Effects of arginine vasopressin on hemodynamic variables and oxygen transport in healthy and endotoxemic sheep. Crit Care Med. 31:(5):2003;1502-1508
118. Martin W., Villani G.M., Jothianandan D., et al. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther. 232:(3):1985;708-716
119. Lomniczi A., Cebral E., Canteros G., et al. Methylene blue inhibits the increase of inducible nitric oxide synthase activity induced by stress and lipopolysaccharide in the medial basal hypothalamus of rats. Neuroimmunomodulation. 8:(3):2000;122-127
120. Mayer B., Brunner F., Schmidt K. Novel actions of methylene blue. Eur Heart J. 14:(Suppl I):1993;22-26
121. Daemen Gubbels C.R., Groeneveld P.H., Groeneveld A.B., et al. Methylene blue increases myocardial function in septic shock. Crit Care Med. 23:(8):1995;1363-1370
122. Donati A., Conti G., Loggi S., et al. Does methylene blue administration to septic shock patients affect vascular permeability and blood volume? Crit Care Med. 30:(10):2002;2271-2277
123. Kirov M.Y., Evgenov O.V., Evgenov N.V., et al. Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study. Crit Care Med. 29:(10):2001;1860-1867
124. López A., Lorente J.A., Steingrub J., et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med. 32:2004;21-30
125. Cragan J.D. Teratogen update: methylene blue. Teratology. 60:(1):1999;42-48
126. Annane D., Sebille V., Charpentier C., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 288:(7):2002;862-871
127. Briegel J., Forst H., Haller M., et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med. 27:(4):1999;723-732
128. Keh D., Boehnke T., Weber Cartens S., et al. Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med. 167:(4):2003;512-520
129. Day T.K. Current development and use of hemoglobin-based oxygen-carrying (HBOC) solutions. J Vet Emerg Crit Care. 13:(2):2003;77-93
130. Belgrave R.L., Hines M.T., Keegan R.D., et al. Effects of a polymerized ultrapurified bovine hemoglobin blood substitute administered to ponies with normovolemic anemia. J Vet Intern Med. 16:(4):2002;396-403
131. Maxson A.D., Giger U., Sweeney C.R., et al. Use of a bovine hemoglobin preparation in the treatment of cyclic ovarian hemorrhage in a miniature horse. J Am Vet Med Assoc. 203:(9):1993;1308-1311
132. Migita R., Gonzales A., Gonzales M.L., et al. Blood volume and cardiac index in rats after exchange transfusion with hemoglobin-based oxygen carriers. J Appl Physiol. 82:(6):1997;1995-2002
133. Gulati A., Sharma A.C., Singh G. Role of endothelin in the cardiovascular effects of diaspirin crosslinked and stroma reduced hemoglobin. Crit Care Med. 24:(1):1996;137-147
134. Gulati A., Sen A.P., Sharma A.C., et al. Role of ET and NO in resuscitative effect of diaspirin cross-linked hemoglobin after hemorrhage in rat. Am J Physiol. 273:(2 Part 2):1997;H827-H836
135. Shoemaker W.C. Diagnosis and treatment of shock and circulatory dysfunction. Grenvik A., Ayres S.M., Holbrook P.R., Shoemaker W.C. Textbook of critical care. 4th edition :2000;92-114 WB Saunders, Philadelphia
136. Cook V.L., Bain F.T. Volume (crystalloid) replacement in the ICU patient. Clin Tech Equine Pract. 2:2003;122-129
137. Corley K.T.T. Monitoring and treating the cardiovascular system in neonatal foals. Clin Tech Equine Pract. 2:2003;42-55
138. Corley K.T.T., Marr C.M. Cardiac monitoring in the ICU patient. Clin Tech Equine Pract. 2:2003;145-155
139. Divers T. Monitoring tissue oxygenation in the ICU patient. Clin Tech Equine Pract. 2:2003;138-144
140. Parry B.W., Anderson G.A., Gay C.C. Prognosis in equine colic: a comparative study of variables used to assess individual cases. Equine Vet J. 15:(3):1983;211-215
141. Parry B.W., Anderson G.A., Gay C.C. Prognosis in equine colic: a study of individual variables used in case assessment. Equine Vet J. 15:(4):1983;337-344
142. Nout Y.S., Corley K.T.T., Donaldson L.L., et al. Indirect oscillometric and direct blood pressure measurement in anesthetized and conscious neonatal foals. J Vet Emerg Crit Care. 12:(2):2002;75-80
143. Muir W.W., Wade A., Grospitch B. Automatic noninvasive sphygmomanometry in horses. J Am Vet Med Assoc. 182:(11):1983;1230-1233
144. Riebold T.W., Evans A.T. Blood pressure measurements in the anesthetized horse: comparison of four methods. Vet Surg. 14:(4):1985;332-337
145. Branson K.R. A clinical evaluation of an oscillometric blood pressure monitor on anesthetized horses. J Equine Vet Sci. 17:1997;537-540
146. Ellis P.M. The indirect measurement of arterial blood pressure in the horse. Equine Vet J. 7:(1):1975;22-26
147. Bailey J.E., Dunlop C.I., Chapman P.L., et al. Indirect Doppler ultrasonic measurement of arterial blood pressure results in a large measurement error in dorsally recumbent anaesthetised horses. Equine Vet J. 26:(1):1994;70-73
148. Hollenberg S.M., Ahrens T.S., Astiz M.E., et al. Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Crit Care Med. 27:(3):1999;639-660
149. Johnson P.C. Autoregulation of blood flow. Circ Res. 59:(5):1986;483-495
150. Robertson C.R., Deen W.M., Troy J.L., et al. Dynamics of glomerular ultrafiltration in the rat. 3. Hemodynamics and autoregulation. Am J Physiol. 223:(5):1972;1191-1200
151. LeDoux D., Astiz M.E., Carpati C.M., et al. Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med. 28:(8):2000;2729-2732
152. Vander A.J. Renal blood flow and glomerular filtration. Renal physiology. 5th edition :1995;24-50 McGraw Hill, New York
153. Lagutchik M.S., Ogilvie G.K., Wingfield W.E., et al. Lactate kinetics in veterinary critical care: a review. J Vet Emerg Crit Care. 6:(2):1996;81-95
154. Smith I., Kumar P., Molloy S., et al. Base excess and lactate as prognostic indicators for patients admitted to intensive care. Intensive Care Med. 27:(1):2001;74-83
155. James J.H., Luchette F.A., McCarter F.D., et al. Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis. Lancet. 354:(9177):1999;505- 508